![Peter Hecht](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 3 M $ in data 31/05/2026
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc., founded in 1998, where he served as Chief Executive Officer & Director from 1998 to 2019.
Dr. Hecht is the founder of Cyclerion Therapeutics, Inc., founded in 2019, where he serves as Director since 2023.
Dr. Hecht is currently Chief Executive Officer & Director at Tisento Therapeutics, Inc. since 2023.
Dr. Hecht is currently Director at Kallyope, Inc. since 2020.
Dr. Hecht is currently Director at Mythic Therapeutics, Inc. Dr. Hecht was Director at Microbia, Inc. Dr. Hecht was Director at Whitehead Institute for Biomedical Research.
Dr. Hecht completed undergraduate and graduate degrees at Stanford University.
Dr. Hecht earned a doctorate from the University of California, Berkeley.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/03/2026 | 559.203 ( 12,91% ) | 2 M $ | 31/05/2026 | |
| 30/03/2026 | 351.037 ( 100% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/04/2019 |
Kallyope, Inc.
 Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Direttore/Membro del Consiglio | 20/02/2020 |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Direttore/Membro del Consiglio | - |
Tisento Therapeutics, Inc.
 Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Amministratore Delegato | 01/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Fondatore | 01/04/2019 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Direttore/Membro del Consiglio | - |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Health Technology |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
